SCH56592 treatment of murine invasive aspergillosis

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 4, 1998, Pages 539-542

  Graybill, John R ^a,b   Bocanegra, Rosie ^a,b   Najvar, Laura K ^a,b   Luther, Michael F ^a   Loebenberg, David ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; POSACONAZOLE;

ANIMAL EXPERIMENT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; COLONY COUNT, MICROBIAL; LUNG; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED ICR; TRIAZOLES;

EID: 0031664896     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.4.539     Document Type: Article

References (25)

1. Flynn, P. M., Cunningham, C. K., Kerkering, T., San Jorge, A. R., Peters, V. B., Pitel, P. A. et al. (1995). Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus mystatin. Journal of Pediatrics, 127, 322-8.
2. Pons, V., Greenspan, D. & Debruin, M. (1993). Therapy for oropharyngeal candidiasis in HIV infected patients: a randomized prospective multicenter study of oral fluconazole versus clotrimazole troches. Journal of the Acquired Immune Deficiency Syndrome 6, 1311-6.
3. Powderly, W. G., Finkelstein, D. M., Feinberg, J., Frame, P., He, W., Van der Horst, C. et al. (1995). A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. New England Journal of Medicine 332, 700-5.
4. Troke, P. F., Andrews, R. J., Pye, G. W. & Richardson, K. (1990). Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Reviews of Infectious Diseases 12, Suppl. 3, S276-80.
5. Wheat, L. J., Hafner, R., Wulfsohn, M., Spencer, P., Squires, K., Powderly, W. et al. (1993). Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Annals of Internal Medicine 118, 610-6.
6. Anaissie, E. J., Bodey, G. P. & Rinaldi, M. G. (1989). Emerging fungal pathogens. European Journal of Clinical Microbiology and Infectious Diseases 8, 323-30.
7. Anaissie, E. J., Kantarjian, H. & Ro, J. (1988). The emerging role of Fusarium infections in patients with cancer. Medicine 67, 77-83.
8. deBock, R. (1994). Epidemiology of invasive fungal infections in bone marrow transplantation. Bone Marrow Transplantation 14, Suppl. 5, S1-2.
9. Mardiak, J., Danisovicová, A., Trupl, J., Sloboda, J., Jesenská, Z. & Krcméry, V. (1993). Three cases of fatal infection due to Fusarium solani in patients with cancer. Clinical Infectious Diseases 17, 930-2.
10. Walsh, T. J. & Pizzo, P. A. (1988). Nosocomial fungal infections: a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Annual Review of Microbiology 42, 517-45.
11. Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H. et al. (1994) NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. American Journal of Medicine 97, 135-44.
12. Khoo, S. H. & Denning, D. W. (1994). Invasive aspergillosis in patients with AIDS. Clinical Infectious Diseases 19, Suppl. 1, S41-8.
13. Coleman, J. M., Hogg, G. G., Rosenfeld, J. V. & Waters, K. D. (1995). Invasive central nervous system aspergillosis: cure with liposomal amphotericin B, itraconazole, and radical surgery - case report and review of the literature. Neurosurgery 36, 858-63.
14. Hiemenz, J. W., Seibel, N. & Walsh, T. (1994). Safety and efficacy of amphotericin B lipid complex (ABLC) in neutropenic patients with life threatening systemic mycoses. Annals of Oncology 5, Suppl. 8, 202.
15. Wingard, J. R., Beals, S. & Santos, G. W. (1987). Aspergillus infections in bone marrow transplant recipients. Bone Marrow Transplantation 2, 175-81.
16. Graybill, J. R. (1996). Lipid formulations for amphotericin B: does the emperor need new clothes? Annals of Internal Medicine 124, 921-3.
17. National Committee for Clinical Laboratory Standards. (1992) Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Proposed Standard M27-P. NCCLS, Villanova, PA.
18. Fothergill, A. W., Sutton, D. A. & Rinaldi, M. G. (1996). An in vitro head-to-head comparison of Schering 56592, amphotericin B, fluconazole, and itraconazole against a spectrum of filamentous fungi. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F89, p. 115. American Society for Microbiology, Washington, DC.
19. Law, D. W. & Denning, D. W. (1996). In vitro activity of Schering 56592, compared with fluconazole and itraconazole against Candida spp. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F88, p. 115. American Society for Microbiology, Washington, DC.
20. Lutz, J. E., Clemons, K. V. & Stevens, D. A. (1996). Efficacy of SCH56592 (SCH) in a murine model of systemic coccidiomycosis. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F100, p. 117. American Society for Microbiology, Washington, DC.
21. Patterson, T. F., Kirkpatrick, W. R., McAtee, R. K. & Loebenberg, D. (1996). Efficacy of SCH56592 in a rabbit model of invasive aspergillosis. In Program and Abstracts of the Thirty-Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, LA, 1996. Abstract F 98, p. 116. American Society of Microbiology, Washington, DC.
22. Albert, M. M., Graybill, J. R. & Rinaldi, M. G. (1991). Treatment of murine cryptococcal meningitis with an SCH39394/AMB combination. Antimicrobial Agents and Chemotherapy 35, 1721-5.
23. Anaissie, E. J., Hachem, R., Legrand, C., Legenne, P., Nelson, P. & Bodey, G. P. (1992). Lack of activity of amphotericin B in systemic murine fusarial infection. Journal of Infectious Diseases 165, 1155-7.
24. Arroyo, J., Medoff, G. & Kobayashi, G. S. (1977). Therapy of murine aspergillosis with amphotericin B in combination with rifampin or 5-fluorocytosine. Antimicrobial Agents and Chemotherapy 11, 21-5.
25. Joly, V., Saint-Julien, L., Carbon, C. & Yeni, P. (1994). In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis. Journal of Infectious Diseases 170, 1331-4.